Lifting The Curtain On How Ritalin Packs Its 1-2 Punch

Date:

May 30, 2006

Source:

American Physiological Society

Summary:

Methylphenidate (Ritalin) elevates norepinephrine levels in the brain to help focus attention and suppresses nerve signal transmissions in the sensory pathways to help block out extraneous stimuli. The study of rats helps explain how the amphetamine-like stimulant aids people with attention deficit and hyperactivity disorders to improve their focus without increasing their motor activity, according to a study in the Journal of Neurophysiology. Little is known about how the drug produces its therapeutic effects.

Share:

Total shares:

FULL STORY

Methylphenidate (Ritalin) elevates norepinephrine levels in the brains of rats to help focus attention while suppressing nerve signal transmissions in the sensory pathways to make it easier to block out extraneous stimuli, a Philadelphia research team has found.

Their report in the Journal of Neurophysiology helps explain how a stimulant aids people with attention deficit and hyperactivity disorders to improve their focus without increasing their motor activity. Methylphenidate, prescribed under the brand name Ritalin, has been used for more than 20 years, mostly in children, to treat attention deficit hyperactivity disorder (ADHD) and attention deficit disorder (ADD). The drug can also help people who don't suffer either disorder to attend better to a cognitive task.

Despite its wide use, little is known about how the drug, a chemical cousin of amphetamines, produces its therapeutic effects. Researchers want to unlock the mystery of why the drug has the paradoxical effect of decreasing hyperactive behavior and increasing the ability to focus, even though it is a stimulant, said Barry Waterhouse, the study's senior author.

"We're developing a series of behavioral and electrophysiological assays for examining the actions of drugs like methylphenidate," Waterhouse said. "If we can show exactly how methylphenidate works, we may be able to produce even more effective drugs and provide a better understanding of the physiology underlying ADHD."

The study, using rats, is the first to document the increase in norepinephrine and suppression of the neuronal response in this sensory pathway of the brain. "Methylphenidate enhances noradrenergic transmission and suppresses mid- and long-latency sensory responses in the primary somatosensory cortex of awake rats," by Philadelphia-based researchers Candice Drouin, University of Pennsylvania; Michelle Page, Thomas Jefferson University; and Barry Waterhouse, Drexel University College of Medicine appears online in the Journal of Neurophysiology, published by The American Physiological Society.

From whiskers to brain

The researchers stimulated rats' whiskers while recording the activity of the neurons in the sensory pathways that convey this sensation from the whiskers to the cerebral cortex. They compared the rat's sensory pathway response to the whisker stimulation when receiving two different doses of methylphenidate. They found that both the low and moderate doses of methylphenidate:

Elevated norepinephrine in the area of the brain that processes information related to whisker movement. Norepinephrine helps transmit sensory information from the periphery to the brain.

Suppressed the long latency phase of the brain's neuronal response to whisker-related sensory stimuli. Suppression of the sensory neuronal response in this way is believed to help filter extraneous stimuli, Waterhouse explained. With the extraneous stimuli out of the way, the individual is better able to attend to the important stimuli.

In addition, the researchers found that the higher dose caused the rats to increase motor activity, while the lower dose did not.

Scientists still have much to learn about methylphenidate, which has an impact on neural circuits throughout the entire brain, not just the sensory pathway studied in this paper, Waterhouse noted. The changes that occur in this sensory pathway may affect other areas of the brain and changes in other areas of the brain may affect this pathway. In addition to sensory pathways, other scientists are studying how the drug affects cognitive and emotional areas of brain.

Next steps

"This experiment adds to our knowledge of what the drug is doing at the cellular level and gives us a springboard to other studies," Waterhouse said. "One question now is, how does the individual's perception of what is an important stimulus factor into the equation?"

Researchers in this area keep in touch and share their results, Waterhouse said. One group, for example, is looking at the drug's effects on dopamine and norepinephrine in the prefrontal cortex, he noted. These results will eventually have to be combined, as changes in one area of the brain are likely to affect other areas.

"We've been thinking about this for a long time," Waterhouse said of his research. "We hope to have a good idea of the drug's action when we put it all together."

One broad question that intrigues researchers is whether ADHD traces back to the same area of the brain as attention deficit disorder, a similar condition but one in which hyperactivity isn't a symptom.

They also want to know whether Ritalin has any toxic or long-lasting effects, not only for ADHD patients, but also for individuals taking the drug who do not suffer from ADHD or ADD. Methylphenidate use is on the rise among college students who solicit prescriptions from friends or siblings diagnosed with ADHD and use the drug to postpone fatigue and stay alert and focused while studying for exams or completing projects, Waterhouse said.

Source and funding

"Methylphenidate enhances noradrenergic transmission and suppresses mid- and long-latency sensory responses in the primary somatosensory cortex of awake rats," by Candice Drouin, Laboratory of Neuromodulation and Behavior, Dept. of Psychiatry, University of Pennsylvania; Michelle Page, Depart. of Neurosurgery, Thomas Jefferson University; and Barry Waterhouse, Dept. of Neurobiology and Anatomy, Drexel University College of Medicine. The study appears in the May issue of the Journal of Neurophysiology published by The American Physiological Society.

Research was supported by a grant from the National Institute of Mental Health (Waterhouse).

American Physiological Society. "Lifting The Curtain On How Ritalin Packs Its 1-2 Punch." ScienceDaily. ScienceDaily, 30 May 2006. <www.sciencedaily.com/releases/2006/05/060530202639.htm>.

American Physiological Society. (2006, May 30). Lifting The Curtain On How Ritalin Packs Its 1-2 Punch. ScienceDaily. Retrieved August 2, 2015 from www.sciencedaily.com/releases/2006/05/060530202639.htm

American Physiological Society. "Lifting The Curtain On How Ritalin Packs Its 1-2 Punch." ScienceDaily. www.sciencedaily.com/releases/2006/05/060530202639.htm (accessed August 2, 2015).

July 31, 2015  School is just around the corner, which means backpacks and packed lunches await your children. One expert offers tips for parents to promote healthy dental habits while away from ... read more

July 29, 2015  By blocking the expression of a certain gene in patients, researchers have contributed to the demonstration of great decreases in the concentration of triglycerides in their ... read more

July 29, 2015  Viewing aquarium displays led to noticeable reductions in blood pressure and heart rate, a research team found in the first study of its kind. They also noted that higher numbers of fish helped to ... read more

Oct. 16, 2013  There is a swirling controversy regarding the suspicion that medications prescribed for the treatment of ADHD (attention-deficit/hyperactivity disorder) primarily act to control disruptive behavior ... read more

Feb. 2, 2011  Ritalin may help improve brain function in adolescent rats that were iron deficient during infancy, according to a neuroscientists. This may have implications for iron-deficient human infants as ... read more